Co-expression of survivin and TERT and risk of tumour-related death in patients with soft-tissue sarcoma.
about
Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCRExpression of the stem cell self-renewal gene Hiwi and risk of tumour-related death in patients with soft-tissue sarcomamiR-199a-5p regulates HIF-1α and OSGIN2 and its expression is correlated to soft-tissue sarcoma patients' outcomeCombined mRNA expression levels of members of the urokinase plasminogen activator (uPA) system correlate with disease-associated survival of soft-tissue sarcoma patientsElevated tumor and serum levels of the hypoxia-associated protein osteopontin are associated with prognosis for soft tissue sarcoma patients.Co-detection of members of the urokinase plasminogen activator system in tumour tissue and serum correlates with a poor prognosis for soft-tissue sarcoma patientsExpression of human Piwi-like genes is associated with prognosis for soft tissue sarcoma patientsCombination of external beam radiotherapy (EBRT) with intratumoral injection of dendritic cells as neo-adjuvant treatment of high-risk soft tissue sarcoma patients.N-(4-Hydroxyphenyl)retinamide induced differentiation with repression of telomerase and cell cycle to increase interferon-gamma sensitivity for apoptosis in human glioblastoma cellsSurvivin, versatile modulation of cell division and apoptosis in cancer.Expression of survivin protein in human colorectal carcinogenesis.Prognostic relevance of hTERT mRNA expression in ductal adenocarcinoma of the pancreasInhibitor of apoptosis proteins as targets for anticancer therapy.N-(4-Hydroxyphenyl) retinamide potentiated paclitaxel for cell cycle arrest and apoptosis in glioblastoma C6 and RG2 cells.Neuronal apoptosis inhibitory protein is overexpressed in patients with unfavorable prognostic factors in breast cancerCellular immunotherapy for soft tissue sarcomas.Impact of expression of the uPA system in sarcomas.Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53.High-Throughput Screening of Myxoid Liposarcoma Cell Lines: Survivin Is Essential for Tumor Growth.Telomerase detection in the diagnosis and prognosis of cancer.Targeting survivin as a potential new treatment for chondrosarcoma of bone.Expression profiles of p63, p53, survivin, and hTERT in skin tumors.CMG2 Expression Is an Independent Prognostic Factor for Soft Tissue Sarcoma Patients.Elevated HERV-K Expression in Soft Tissue Sarcoma Is Associated with Worsened Relapse-Free Survival.Loss of 13q14-q21 and gain of 5p14-pter in the progression of leiomyosarcoma.Inverse prognostic impact of ErbB2 mRNA and protein expression level in tumors of soft tissue sarcoma patients.[Sarcoma gene signatures].Role of survivin gene promoter polymorphism (-31G>C) in susceptibility and survival of esophageal cancer in northern India.Prognostication of soft tissue sarcomas based on chromosome 17q gene and protein status: evaluation of TOP2A, HER-2/neu, and survivin.
P2860
Q24795409-1A3CF705-85F5-4BFC-AED8-787C50665C69Q28261947-626FBD5A-17D1-4B3A-A9F3-1D0C577B2DECQ30313534-CCA13EFA-980C-47C4-BEB0-D2CEEB4C6593Q31021361-F7672836-490D-481F-ADE5-19E35E655B1DQ33551004-400ED05B-460B-4DE7-9BE9-ADE35E2385DDQ33723658-9AFD985A-40B0-41AF-9882-0AF19F2A1431Q34285094-4B65F0AE-FDB1-4F99-B49A-38EA2BC6EBB3Q34560857-F21C18BF-20BD-4AC0-BB5A-9AC55CF86B0AQ35013084-43A26AA5-49C1-45A9-83D4-F26238DFDF65Q35591693-52A6E168-BE43-4FF2-B5CD-2B88C8E58CD7Q36178566-D24420B8-AD72-43A7-B479-0C814090BBECQ36840276-1CC17B83-6AD5-449C-9530-86D7169650DBQ36950485-30437BF2-5B46-4227-A98C-B911BA757909Q37196047-D71E9325-C2AE-4226-A573-F06E7BC97C8BQ37222549-3DE52CD0-82D7-40CD-9992-614995F43C7FQ37991779-9C042C46-B1D5-4C41-AC87-7D75DE6EDA62Q38111811-AFFA34C2-300E-4AB5-896E-0E65AC72F002Q40596377-3C9883D3-8A13-48EE-BDEF-532A18E44469Q41026125-C459DEF2-03E7-4523-A2D1-65B9F550C672Q42183561-C0CF1F84-5153-4486-9404-AE2F0B626DD3Q42419178-33325E3D-7209-4F28-A7C5-05F415F4B9D4Q42465007-B04C8982-2A10-4E98-8016-6FFBF2FD5CC6Q47320197-66BA817F-BA46-414D-AFFA-2F680D7CF080Q50325209-FB701CAE-4D5C-427A-9245-499865E0988BQ53376961-80A7A129-24AA-4BC3-A235-5C75D31C75FAQ54361340-749DFF4D-9017-4EE2-8910-CB9BDA77F39CQ54389752-195C0249-D199-4D66-ACA0-CB717B7141CEQ54405955-BFE693DA-32B2-45E0-BFF0-8DD8C474E218Q54540314-3974E867-6E50-47F7-BCA9-7C95F13A5837
P2860
Co-expression of survivin and TERT and risk of tumour-related death in patients with soft-tissue sarcoma.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Co-expression of survivin and ...... ents with soft-tissue sarcoma.
@en
Co-expression of survivin and ...... ents with soft-tissue sarcoma.
@nl
type
label
Co-expression of survivin and ...... ents with soft-tissue sarcoma.
@en
Co-expression of survivin and ...... ents with soft-tissue sarcoma.
@nl
prefLabel
Co-expression of survivin and ...... ents with soft-tissue sarcoma.
@en
Co-expression of survivin and ...... ents with soft-tissue sarcoma.
@nl
P2093
P1433
P1476
Co-expression of survivin and ...... ents with soft-tissue sarcoma.
@en
P2093
Christine Lautenschläger
Frank Bartel
Hannelore Schmidt
Matthias Bache
Matthias Kappler
Peter Würl
Thomas Köhler
P304
P356
10.1016/S0140-6736(02)07990-4
P407
P577
2002-03-01T00:00:00Z